Evidence map›Paper›PMID 18757535›Full record

ArticleJournal of bacteriology2008

Evolutionary comparison of ribosomal operon antitermination function.

Kristine B Arnvig, Shirley Zeng, Selwyn Quan, Alexander Papageorge, Ning Zhang, Anuradha C Villapakkam, Catherine L Squires

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of bacteriology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. mBio · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Processive Antitermination.Microbiology spectrum · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kristine B ArnvigDivision of Mycobacterial Research, National Institute for Medical Research, London, UK.
Shirley Zeng
Selwyn Quan
Alexander Papageorge
Ning Zhang
Anuradha C Villapakkam
Catherine L Squires
Stanford University · USTufts University · US

Funding

FUSION OF THE RIBOSOMAL RNA PROMOTER TO OTHER OPERONSR01GM024751 · NIGMS · TUFTS UNIVERSITY BOSTON · PI SQUIRES, CATHERINE L · 1985 to 2007
$4.0M
Medical Research Council MC_U117581288NIGMS NIH HHS GM24751NIGMS NIH HHS R01 GM024751
6 · The paper itself

Abstract

Transcription antitermination in the ribosomal operons of Escherichia coli results in the modification of RNA polymerase by specific proteins, altering its basic properties. For such alterations to occur, signal sequences in rrn operons are required as well as individual interacting proteins. In this study we tested putative rrn transcription antitermination-inducing sequences from five different bacteria for their abilities to function in E. coli. We further examined their response to the lack of one known rrn transcription antitermination protein from E. coli, NusB. We monitored antitermination activity by assessing the ability of RNA polymerase to read through a factor-dependent terminator. We found that, in general, the closer the regulatory sequence matched that of E. coli, the more likely there was to be a successful antitermination-proficient modification of the transcription complex. The rrn leader sequences from Pseudomonas aeruginosa, Bacillus subtilis, and Caulobacter crescentus all provided various levels of, but functionally significant antitermination properties to, RNA polymerase, while those of Mycobacterium tuberculosis and Thermotoga maritima did not. Possible RNA folding structures of presumed antitermination sequences and specific critical bases are discussed in light of our results. An unexpected finding was that when using the Caulobacter crescentus rrn leader sequence, there was little effect on terminator readthrough in the absence of NusB. All other hybrid antitermination system activities required this factor. Possible reasons for this finding are discussed.

Indexed as

Evolution, MolecularBacillus subtilisBacterial ProteinsCaulobacter crescentusDNA-Directed RNA PolymerasesEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialOperonPseudomonas aeruginosaRNA, RibosomalSpecies SpecificityTerminator Regions, GeneticTranscription, GeneticBacterial ProteinsDNA-Directed RNA PolymerasesEscherichia coli ProteinsRNA, Ribosomal

Identifiers

PMID18757535
PMCPMC2580698
OpenAlexW2033197657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.